The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit.
Read More
It would seem intuitive, then, that withholding lithium, which is toxic in overdose, from a suicidal patient is a safe move. However, intuition doesn’t match up with the evidence here.
Read More
With so many medications available to treat ADHD, wouldn’t it be nice to know if some are better than others? In this comprehensive meta-analysis, researchers sought to compare the relative efficacy and tolerability of both stimulant and non-stimulant medications for ADHD in children and adults.
Read More
During pregnancy, untreated depression significantly increases the risk that the infant will fail to develop adequate levels of cerebral inhibition. That’s a measure of the infant’s ability to filter out irrelevant stimuli, and it’s the first sign that development is not on an optimal track.
Read More
“To love and work” was how Freud saw the goal of psychiatric treatment. Mental illness robs people of many meaningful roles, from work to parenting. We spoke with Marie Yap, director of the award-winning Parenting Strategies program, to learn how to help our patients function better as parents and prevent psychiatric disorders in their children.
Read More
Genetic tests are marketed with a bold claim: that a handful of genes can predict medication response. AssureRx’s GeneSight is the most popular of these tests, and in 2015 we reviewed the evidence behind its panel. In short, it was lacking, but the company has just released new data that may move it a little closer to the mainstream.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
